Three-dimensionally Printed Hyrax Versus Conventional Hyrax for Maxillary Arch Expansion in Adolescents
1 other identifier
interventional
22
1 country
1
Brief Summary
This clinical trial aims to compare the skeletal and dental effects of conventional Hyrax expanders and 3D-printed Hyrax expanders in adolescent patients with maxillary transverse deficiency. Using cone-beam computed tomography (CBCT) and digital models, the study evaluates the precision, customization, and treatment outcomes of both appliance types to inform evidence-based orthodontic treatment planning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 24, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
ExpectedFebruary 13, 2026
February 1, 2026
1 year
January 24, 2026
February 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Amount of mid-palatal suture opening.
The amount of suture separation measured in millimeters in the axial plane through CBCT X-ray
Three weeks
Secondary Outcomes (6)
Amount of dental expansion
Three weeks
The amount of tipping of maxillary molars and premolars.
Three weeks
Change of buccal alveolar bone thickness.
Three weeks
Pain assessment
Three weeks
Oral health-related quality of life.
Three weeks
- +1 more secondary outcomes
Study Arms (2)
Group A: 3D-Printed Hyrax Expander
EXPERIMENTALAdolescent patients diagnosed with transverse maxillary arch constriction will undergo maxillary expansion using a three-dimensionally printed Hyrax expander.
Group B: Conventionally Fabricated Hyrax Expander
ACTIVE COMPARATORAdolescent patients diagnosed with transverse maxillary arch constriction will undergo maxillary expansion using using a conventionally fabricated Hyrax expander.
Interventions
Group A : A 3D-printed Hyrax expander designed for rapid maxillary expansion in orthodontic treatment. The device is manufactured using additive manufacturing technology for a customized fit.
Group B: A conventionally fabricated Hyrax expander used for rapid maxillary expansion . The device is made using traditional laboratory techniques.
Eligibility Criteria
You may qualify if:
- Patients aged between 12 to 17 years.
- Skeletal age ranges from CVMS 3 to CVMS 5.
- Skeletal maxillary transverse deficiency with/without crossbite.
- Cooperative and able to attend follow-up visits.
You may not qualify if:
- Previous orthodontic treatment.
- Craniofacial syndromes, or cleft lip and/or palate.
- Patients with vertical growth pattern.
- Very bad oral hygiene and active periodontal disease.
- Vulnerable groups such as individuals with cognitive impairments or intellectual disabilities and individuals with severe mental health disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of dentistry, Ain Shams univeristy
Cairo, Cairo Governorate, 11566, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2026
First Posted
February 13, 2026
Study Start
August 1, 2025
Primary Completion
August 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share